4 resultat
Twelve compounds were isolated from the herb of Chenopodium ambrosioides, and their structures were identified by spectroscopic methods as kaempferol-7-O-alpha-L-rhamnopyranoside (1), kaempferol-3,7-di-O-alpha-L-rhamnopyranoside (2), patuletin (3), quercetin-7-O-alpha-L-rhamnopyranoside (4),
Nine glycosides of patuletin, 6-methoxykaempferol and spinacetin from Good King Henry (Chenopodium bonus-henricus L.) were investigated for neuroprotective, anti-α-glucosidase and lipase activities. All tested flavonoids (100 µM) showed statistically significant neuroprotective
Three new flavonoid glycosides (7-9) named patuletin-3-O-(5″'-О-Е-feruloyl)-β-d-apiofuranosyl(1→2)[β-d-glucopyranosyl (1→6)]-β-d-glucopyranoside (7), spinacetin-3-O-(5″'-О-Е-feruloyl)-β-d-apiofuranosyl (1→2)[β-d-glucopyranosyl(1→6)]-β-d-glucopyranoside (8) and
Chenopodium foliosum Asch. has been recognised by Bulgarian legislation as a medicinal plant. The decoction of its aerial parts has been used for treatment of cancer, as an immunostimulant and antioxidant drug. An UHPLC-HRMS profiling method was used for a comprehensive study of flavonoid